000			03978ntm a2200313 i 4500
999			_c13030 _d13030
001			12102116
005			20220404103831.0
008			150118s2022 ua a f bm 000 0 eng |
040			_aEG-EULC _cEG-EULC _erda
041	0		_aeng _bara
082	0	4	_a615.1 _bM.S.T _222
100	1		_aAbdulazeem, Muhammad Muneeb Muhammad, _933917 _eauthor.
245	1	0	_aTargeting brain insulin signaling pathway for modulation of cognitive impairment in a rat model of type II diabetes mellitus / _cBy Muhammad Muneeb Muhammad Abdulazeem, (Bachelor degree of Pharmacy (2015), Teaching Assistant, Pharmacology, Toxicology & Biochemistry Department, Faculty of Pharmacy, Future University in Egypt (FUE)); Supervision of Dr. Samira Saleh Mostafa,(Professor of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Dr. Suzan Mohamed Mansour, Associate Professor of Pharmacology and Toxicology, Faculty of Pharmacy, Future University in Egypt, Dr. Reham Atef Muhamed, Faculty of Pharmacy, Cairo University).
246	1	5	_aإستهداف مسار إشارة الأنسولين بالمخ لتطبيع ضعف الإدراك في نموذج الجرذ المصاب بالسكري من النوع الثاني
264		1	_c2022.
300			_axii, 194 pages, 6 pages : _billustrations (some color) ; _c22 cm
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
500			_aSupervision of Dr. Samira Saleh Mostafa,(Professor of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Dr. Suzan Mohamed Mansour, Associate Professor of Pharmacology and Toxicology, Faculty of Pharmacy, Future University in Egypt, Dr. Reham Atef Muhamed, Faculty of Pharmacy, Cairo University)
502			_aThesis (M.Sc.)-Cairo University, Faculty of pharmacy, Department of Pharmacology & Toxicology, 2022.
504			_aIncludes bibliographical references.
520	3		_aThe study aimed to explore the possible neuroprotective effects of VitD and/or RSV in T2DM-induced cognitive deficits. It investigates the crosstalk between insulin/AKT/GSK-3β and the canonical/non-canonical Wnt/β-catenin signaling in the hippocampus. T2DM was induced by a fat sucrose diet and a single dose of streptozotocin (STZ). Diabetic rats were randomly allocated into 4 groups, a diabetic control and three groups treated for 5 weeks with RSV (15 mg/kg/day, PO), VitD (cholecalciferol, 500 IU/kg/day, PO) or their combination. A normal-control group was run concomitantly. We determined antineuropathic effects (cognitive function and histopathological examination), metabolic abnormalities (glucose, insulin, HOMA-IR, FFA and lipid profile), neuro-inflammation (IL-23, IL-27), Wnt/β-catenin signaling, canonical (ApoE-4, Wnt5a, pS9 GSK-3β, pS675 β-catenin, pS37 β-catenin) and non-canonical (RhoA, Rac1, p-Akt ), blood brain barrier integrity markers (Annexin A1, claudin 3 and VE-cadherin), dementia hallmarks (p-Tau and Aβ protein), and gene expression of insulin and α7nACh receptors. Treatment with VitD and/or RSV significantly hampered T2DM-induced disturbances in metabolic profile and stimulated both canonical/noncanonical Wnt/β-catenin cassettes in the hippocampus with activation of their downstream molecules. They hindered hippocampal ApoE-4 content, Tau hyperphosphorylation and Aβ deposition. The amended pathways were reflected as improved performance in Morris water maze and novel object recognition tests besides restored histological architecture. The current study provides evidence for expanding the use of VitD and RSV against T2DM-induced cognitive and memory impairment. The study also suggests a superior benefit of combining both treatments over either drug alone
546			_aText in English, abstracts in English and Arabic.
650		0	_aPharmacology
856	4	0	_3DSpace electronic resources _uhttp://repository.fue.edu.eg/xmlui/handle/123456789/5779
942			_cTHESIS _2ddc